Resources Contact Us Home
Method for selecting compounds for treating ischemia-related cellular damage

Image Number 12 for United States Patent #6379882.

A method of screening for and treating subjects with a therapeutically effective amount of a compound that is effective in reducing cellular damage related to an ischemic condition, such as stroke or glaucoma. Test compounds are selected and therapeutically effective amount determined based on the relative efficacy of test compounds in preventing cell death in primary cultures of excitable cells, such as retinal ganglion cells, in vitro.

  Recently Added Patents
Proton conducting electrolytes with cross-linked copolymer additives for use in fuel cells
Integrating multimedia capabilities with circuit-switched calls
Integrated bug tracking and testing
Fluid-borne particle detector
Battery power management system and method
Etch resistant clearcoat
Automated tuning in a virtual machine computing environment
  Randomly Featured Patents
Semiconductor test equipment with concentric pogo towers
Electrolytic method for producing ammonium paratungstate from cemented tungsten carbide
Packed bus selection of multiple pixel depths in palette devices, systems and methods
Spring element for a clutch
10,10-dihydro-10-[(substituted-carbonyl)imino]-10-ph enyl-10H-phenoxaphosphines compositions containing same and therapeutic methods of use
Non-reversing mirror device with perceived depth perspective
Stator winding having radial aligned wraps
System and method for person or object position location utilizing impulse radio
Method and apparatus for updating inter-server communication software
Pen needle magazine